Discovery of new signalling pathway creates hope for hormone therapy resistance

[News]

A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant.

More... (http://www.news-medical.net/news/20130402/Discovery-of-new-signalling-pathway-creates-hope-for-hormone-therapy-resistance.aspx)